Table 4.
Pre-treatment and post-treatment clinical characteristics of type 2 diabetes patients with hypertriglyceridemia treated with fenofibrate.
| Parameters | Pre-treatment (N=25) | Post-treatment (N=25) | P value |
|---|---|---|---|
| BMI (kg/m2) | 26.46±4.60 | 26.37±4.59 | 0.209 |
| SBP (mmHg) | 125.00±7.65 | 125.48±6.76 | 0.668 |
| DBP (mmHg) | 74.24±8.74 | 73.92±7.30 | 0.831 |
| TC (mmol/L) | 4.62±0.66 | 4.83±0.69 | 0.145 |
| HDL-C(mmol/L) | 1.25±0.29 | 1.47±0.27 | <0.001 |
| LDL -C(mmol/L) | 2.80±0.53 | 2.82±0.66 | 0.845 |
| TG (mmol/L) | 3.05±0.86 | 1.84±0.76 | <0.001 |
| FBG (mmol/L) | 7.43±1.01 | 7.32±1.00 | 0.215 |
| Hcy (μmol/L) | 17.08±4.30 | 16.24±3.88 | 0.283 |
| HsCRP (mg/L) | 2.44±1.61 | 1.59±1.39 | 0.020 |
| AST (U/L) | 22.08±7.33 | 23.84±9.04 | 0.322 |
| ALT (U/L) | 26.00±5.69 | 24.44±11.64 | 0.518 |
| CR (μmol/L) | 71.92±13.74 | 76.10±17.29 | 0.164 |
| CK (U/L) | 84.64±27.69 | 91.20±37.28 | 0.307 |
BMI – body mass index; SBP – systolic blood pressure; DBP – diastolic blood pressure; TC – total cholesterol; HDL-C – high-density lipoprotein cholesterol; LDL-C – low-density lipoprotein cholesterol; TG – triglycerides; FBG – fasting blood glucose; Hcy – homocysteine; hsCRP – high-sensitivity C-reactive protein; AST – aspartate aminotransferase; ALT – alanine aminotransferase; CR – creatinine; CK – creatine kinase.